|
gptkbp:instanceOf
|
gptkb:anabolic_steroid
|
|
gptkbp:alsoKnownAs
|
gptkb:methandrostenolone
gptkb:Dianabol
|
|
gptkbp:ATCCode
|
A14AA03
|
|
gptkbp:bannedIn
|
gptkb:World_Anti-Doping_Agency
|
|
gptkbp:broadcastOn
|
gptkb:Schedule_III_(US)
|
|
gptkbp:CASNumber
|
72-63-9
|
|
gptkbp:chemicalFormula
|
C20H28O2
|
|
gptkbp:developedBy
|
gptkb:Ciba
|
|
gptkbp:eliminationHalfLife
|
3-6 hours
|
|
gptkbp:introduced
|
1955
|
|
gptkbp:legalStatus
|
controlled substance in many countries
|
|
gptkbp:MeSH_ID
|
D008687
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:molecularWeight
|
300.44 g/mol
|
|
gptkbp:notableFor
|
popular among bodybuilders
|
|
gptkbp:origin
|
synthetic
|
|
gptkbp:pregnancyCategory
|
X (contraindicated)
|
|
gptkbp:PubChem_CID
|
6321424
DB00634
|
|
gptkbp:routeOfAdministration
|
oral
intramuscular injection
|
|
gptkbp:sideEffect
|
acne
liver toxicity
gynecomastia
increased aggression
|
|
gptkbp:structureType
|
17α-alkylated derivative of testosterone
|
|
gptkbp:UNII
|
Y9R5GVW4YK
|
|
gptkbp:usedFor
|
muscle growth
|
|
gptkbp:bfsParent
|
gptkb:methandrostenolone
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
metandienone
|